Author:
Urata Motoki,Narita Yuki,Kadowaki Daisuke,Tanoue Kazutaka,Tashiro Issei,Fukunaga Masaki,Shibata Akitomo,Yoshida Yutaka,Soejima Kazuaki,Hirata Sumio
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Urology,Nephrology
Reference14 articles.
1. Aoki Y. Bactericidal activity of arbekacin against methicillin-resistant Staphylococcus aureus. Comparison with that of vancomycin. Jpn J Antibiot. 1994;47:640–6.
2. Okada K, Kimura T, Mikamo H, Kasahara K, Seki M, Takakuraet S, et al. Clinical practice guidelines for therapeutic drug monitoring of arbekacin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring. J Infect Chemother. 2014;20:1–5.
3. Yamasaku F, Suzuki Y, Shinkai S, Shomura T, Komiya I. Pharmacokinetics of HBK in healthy adult volunteers. Chemotherapy. 1986;34:117–28.
4. Totsuka K, Shimizu K, Mitomi N, Niizato T, Araake M. Evaluation of once-daily administration of arbekacin. Experimental study and determination of pharmacokinetic properties in man. Jpn J Antibiot. 1994;47:676–92.
5. Fillastre JP, Leroy A, Humbert G, Moulin B, Bernadet P, Josse S. Pharmacokinetics of habekacin in patients with renal insufficiency. Antimicrob Agents Chemother. 1987;31:575–7.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献